Contemporary Medicine is categorized under Doctors in Willowbrook, IL and active since 2000.
Contemporary Medicine was established in 2000, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Rebecca Ayre, Office Manager at the company’s single location by writing to 322 Burr Ridge Parkway, Willowbrook, Illinois IL 60527 or by phoning (630) 321-9010. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Contemporary Medicine |
| Contact Person: | Rebecca Ayre, Office Manager |
| Address: | 322 Burr Ridge Parkway, Willowbrook, Illinois 60527 |
| Phone Number: | (630) 321-9010 |
| Website Address: | contemporarymedicine.net |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2000 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6214930 |
| Share This Business: |
Contemporary Medicine was started in 2000 to provide professional Doctors under the SIC code 8011 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Rebecca Ayre, Office Manager for inquiries that concern Contemporary Medicine by calling the company number (630) 321-9010, as your correspondence is most welcome. Additionally, the physical location of the single location of Contemporary Medicine can be found at the coordinates 41.75123,-87.91194 as well as the street address 322 Burr Ridge Parkway in Willowbrook, Illinois 60527.
For its online presence, you may visit Contemporary Medicine’s website at contemporarymedicine.net and engage with its social media outlets through on Twitter and on Facebook.